Folotyn is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Allos Therapeutics. The primary component is Pralatrexate.
| Product ID | 48818-001_1ed02005-69ec-499f-bf23-3100b06651f8 |
| NDC | 48818-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Folotyn |
| Generic Name | Pralatrexate |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2009-09-24 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022468 |
| Labeler Name | Allos Therapeutics |
| Substance Name | PRALATREXATE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2009-09-24 |
| Marketing End Date | 2023-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022468 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-09-24 |
| Marketing Category | NDA |
| Application Number | NDA022468 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-09-24 |
| Ingredient | Strength |
|---|---|
| PRALATREXATE | 20 mg/mL |
| SPL SET ID: | 5e4cf15b-bf7b-4b83-863e-e9ef27741a51 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 48818-001 | Folotyn | pralatrexate |
| 72893-003 | Folotyn | pralatrexate |
| 72893-005 | Folotyn | pralatrexate |
| 65219-550 | Pralatrexate | Pralatrexate |
| 65219-552 | Pralatrexate | Pralatrexate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FOLOTYN 78881722 3743409 Live/Registered |
Allos Therapeutics, Inc. 2006-05-11 |
![]() FOLOTYN 77939090 3887969 Dead/Cancelled |
Allos Therapeutics, Inc. 2010-02-18 |